RCEL AVITA Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RCEL

Price (delayed)

$8.73

Market cap

$224.42M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.4

Enterprise value

$243.82M

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection ...

Highlights
The gross profit has grown by 39% year-on-year and by 8% since the previous quarter
The revenue has grown by 37% YoY and by 8% from the previous quarter
RCEL's quick ratio is up by 31% since the previous quarter but it is down by 6% year-on-year
AVITA Medical's equity has decreased by 42% YoY and by 22% QoQ
The net income has contracted by 33% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://avitamedical.com
Peers: NVCR NVAX

Key stats

What are the main financial stats of RCEL
Market
Shares outstanding
25.71M
Market cap
$224.42M
Enterprise value
$243.82M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.55
Price to sales (P/S)
4.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.73
Earnings
Revenue
$51.57M
EBIT
-$34.17M
EBITDA
-$32.79M
Free cash flow
-$39.39M
Per share
EPS
-$1.4
Free cash flow per share
-$1.56
Book value per share
$1.92
Revenue per share
$2.04
TBVPS
$4.39
Balance sheet
Total assets
$111.64M
Total liabilities
$61.89M
Debt
$41.51M
Equity
$49.06M
Working capital
$90.81M
Liquidity
Debt to equity
0.85
Current ratio
7.88
Quick ratio
7.33
Net debt/EBITDA
-0.59
Margins
EBITDA margin
-63.6%
Gross margin
84.9%
Net margin
-68.6%
Operating margin
-82.7%
Efficiency
Return on assets
-38.1%
Return on equity
-54.8%
Return on invested capital
-60.3%
Return on capital employed
-34.7%
Return on sales
-66.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RCEL stock price

How has the AVITA Medical stock price performed over time
Intraday
0.11%
1 week
2.46%
1 month
-42.34%
1 year
-47.47%
YTD
-36.37%
QTD
-45.54%

Financial performance

How have AVITA Medical's revenue and profit performed over time
Revenue
$51.57M
Gross profit
$43.79M
Operating income
-$42.66M
Net income
-$35.38M
Gross margin
84.9%
Net margin
-68.6%
The operating income has plunged by 55% YoY and by 18% from the previous quarter
The gross profit has grown by 39% year-on-year and by 8% since the previous quarter
The revenue has grown by 37% YoY and by 8% from the previous quarter
The net income has contracted by 33% YoY and by 5% from the previous quarter

Growth

What is AVITA Medical's growth rate over time

Valuation

What is AVITA Medical stock price valuation
P/E
N/A
P/B
4.55
P/S
4.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.73
The company's EPS fell by 31% YoY and by 4.5% QoQ
AVITA Medical's equity has decreased by 42% YoY and by 22% QoQ
The stock's price to book (P/B) is 24% less than its last 4 quarters average of 6.0 and 7% less than its 5-year quarterly average of 4.9
The P/S is 72% below the 5-year quarterly average of 15.3 and 48% below the last 4 quarters average of 8.2
The revenue has grown by 37% YoY and by 8% from the previous quarter

Efficiency

How efficient is AVITA Medical business performance
AVITA Medical's return on equity has shrunk by 86% YoY and by 20% QoQ
The ROIC has plunged by 54% YoY but it has grown by 20% from the previous quarter
The return on assets has declined by 45% year-on-year
The company's return on sales rose by 6% YoY and by 6% QoQ

Dividends

What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RCEL.

Financial health

How did AVITA Medical financials performed over time
The total assets is 80% greater than the total liabilities
The total assets is up by 38% since the previous quarter and by 14% year-on-year
RCEL's quick ratio is up by 31% since the previous quarter but it is down by 6% year-on-year
RCEL's debt is 15% smaller than its equity
AVITA Medical's equity has decreased by 42% YoY and by 22% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.